Table 5.
Variable | A Patients with legal involvement data N = 609 |
B Patients without legal involvement data N = 42 |
P-value Unadjusted, overall group comparison (A vs B) |
---|---|---|---|
Age, mean (SD) | 42.9 (12.0) | 41.6 (13.2) | 0.480 |
Male gender, n (%) | 380 (62%) | 31 (74%) | 0.185 |
Ethnicity -- Caucasian, n (%) | 334 (55%) | 20 (48%) | 0.533 |
-African-American, n (%) | 204 (34%) | 15 (36%) | |
-Other ethnic group, n (%) | 71 (12%) | 7 (17%) | |
Uninsured, n (%) | 105 (18%) | 13 (35%) | 0.017 |
PANSS total, mean (SD) | 86.7 (19.9) | 88.2 (21.2) | 0.652 |
SF36 MCS, mean (SD) | -1.04 (1.32) | -1.71 (1.34) | 0.002 |
SF36 PCS, mean (SD) | -0.44 (1.04) | -0.22 (1.02) | 0.189 |
Past year psych hospitalization: None, n (%) | 417 (70%) | 24 (60%) | 0.216 |
ER past 3 months, n (%) | 163 (28%) | 17 (44%) | 0.043 |
Lifetime substance use disorder diagnosis, n (%) | 262 (43%) | 26 (62%) | 0.024 |
Use of alcohol to intoxication, n (%) | 48 (8%) | 6 (17%) | 0.109 |
Any use of cannabis, n (%) | 79 (13%) | 9 (25%) | 0.077 |
Any use of cocaine, n (%) | 29 (5%) | 2 (6%) | 0.694 |
MPR ≥ 80%, n (%) | 238 (44%) | 11 (28%) | 0.067 |
MPR, mean (SD) | 0.53 (0.43) | 0.39 (0.41) | 0.043 |
Discontinued study, n (%) | 156 (26%) | 38 (90%) | < 0.001 |
Mean days to study discontinuation, mean (SD) | 319.5 (88.9) | 123.5 (125.6) | < 0.001 |